Advanstar reports first-half revenues up 13%

Share this article:
Advanstar reported first-half revenues up 13% year-on-year, from $146 million to $165 million--though its life sciences division was nearly flat for Q2. Revenues from Advanstar life sciences properties rose by 3% for the period, as overall revenues rose 6%, largely on a 24% jump in the firm's power sports division. 
Share this article:
close

Next Article in News

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.